Literature DB >> 2326200

A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses.

S Y Le1, M H Malim, B R Cullen, J V Maizel.   

Abstract

A series of unusual folding regions (UFR) immediately 3' to the cleavage site of the outer membrane protein (OMP) and transmembrane protein (TMP) were detected in the envelope gene RNA of the human immunodeficiency virus (HIV-1, HIV-2) and simian immunodeficiency virus (SIV) by an extensive Monte Carlo simulation. These RNA secondary structures were predicted to be both highly stable and statistically significant. In the calculation, twenty-five different sequence isolates of HIV-1, three isolates of HIV-2 and eight sequences of SIV were included. Although significant sequence divergence occurs in the env coding regions of these viruses, a distinct UFR of 234-nt is consistently located ten nucleotides 3' to the cleavage site of the OMP/TMP in HIV-1, and a 216-nt UFR occurs forty-six and forty-nine nucleotides downstream from the OMP/TMP cleavage site of HIV-2 and SIV, respectively. Compensatory base changes in the helical stem regions of these conserved RNA secondary structures are identified. These results support the hypothesis that these special RNA folding regions are functionally important and suggest that the role of this sequence as the Rev response element (RRE) is mediated by secondary structure as well as primary RNA sequence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2326200      PMCID: PMC330534          DOI: 10.1093/nar/18.6.1613

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

3.  Globin mRNA sequences: analysis of base pairing and evolutionary implications.

Authors:  W Salser
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

4.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Secondary structure of the Tetrahymena ribosomal RNA intervening sequence: structural homology with fungal mitochondrial intervening sequences.

Authors:  T R Cech; N K Tanner; I Tinoco; B R Weir; M Zuker; P S Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  An energy model that predicts the correct folding of both the tRNA and the 5S RNA molecules.

Authors:  C Papanicolaou; M Gouy; J Ninio
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: the AIDS Behavioral Research Project.

Authors:  R Stall; L McKusick; J Wiley; T J Coates; D G Ostrow
Journal:  Health Educ Q       Date:  1986

8.  Improved free-energy parameters for predictions of RNA duplex stability.

Authors:  S M Freier; R Kierzek; J A Jaeger; N Sugimoto; M H Caruthers; T Neilson; D H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  A method for assessing the statistical significance of RNA folding.

Authors:  S Y Le; J V Maizel
Journal:  J Theor Biol       Date:  1989-06-22       Impact factor: 2.691

10.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.

Authors:  M Emerman; M Guyader; L Montagnier; D Baltimore; M A Muesing
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  45 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  Prediction of common secondary structures of RNAs: a genetic algorithm approach.

Authors:  J H Chen; S Y Le; J V Maizel
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

3.  A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure.

Authors:  S Chen; S Y Le; D L Newton; J V Maizel; S M Rybak
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

Review 4.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

5.  RNA molecules with structure dependent functions are uniquely folded.

Authors:  Shu-Yun Le; Kaizhong Zhang; Jacob V Maizel
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

6.  Minimal Rev-response element for type 1 human immunodeficiency virus.

Authors:  X J Huang; T J Hope; B L Bond; D McDonald; K Grahl; T G Parslow
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Structural RNA has lower folding energy than random RNA of the same dinucleotide frequency.

Authors:  Peter Clote; Fabrizio Ferré; Evangelos Kranakis; Danny Krizanc
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

8.  Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2.

Authors:  E D Garrett; B R Cullen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.

Authors:  D J Chin
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Identification of feline immunodeficiency virus rev gene activity.

Authors:  T Kiyomasu; T Miyazawa; T Furuya; R Shibata; H Sakai; J Sakuragi; M Fukasawa; N Maki; A Hasegawa; T Mikami
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.